Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome
Condition: Steroid-Sensitive Nephrotic Syndrome Intervention: Drug: Rituximab Sponsors: Children's Hospital of Fudan University; Children's Hospital of Nanjing Medical University; The Children's Hospital of Zhejiang University School of Medicine; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Wuhan Union Hospital, China; Anhui Provinc ial Children's Hospital; Shanghai Children's Hospital; Children's Hospital Affiliated to Zhengzhou University/Henan Children's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | China Health | Hospitals | Nephrotic Syndrome | Pediatrics | Research | Rituxan